1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Feng, Y. Klein, B.K. Mcwherter, C.A. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 259 524 541 10.1006/jmbi.1996.0337 8676386 Three-dimensional solution structure and backbone dynamics of a variant of human interleukin-3. 1996 US Biochemistry BICHAW 0033 0006-2960 34 6540 1H, 13C, and 15N NMR Resonance Assignments, Secondary Structure, and Backbone Topology of a Variant of Human Interleukin-3 1995 10.2210/pdb1jli/pdb pdb_00001jli 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 12844.856 INTERLEUKIN 3 DEL(1-13), V14A, N18I, T25H, Q29R, L32N, F37P, G42S, Q45M, N51R, R55T, E59L, N62V, S67H, Q69E, DEL(126-133) 1 man polymer MULTI-CSF no no ANCSIMIDEIIHHLKRPPNPLLDPNNLNSEDMDILMERNLRTPNLLAFVRAVKHLENASAIESILKNLLPCLPLATAAPT RHPIHIKDGDWNEFRRKLTFYLKTLENAQAQQ ANCSIMIDEIIHHLKRPPNPLLDPNNLNSEDMDILMERNLRTPNLLAFVRAVKHLENASAIESILKNLLPCLPLATAAPT RHPIHIKDGDWNEFRRKLTFYLKTLENAQAQQ A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample 9606 Homo sapiens 562 Escherichia coli JM101 PMON 13302 database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1997-06-16 1 1 2008-03-24 1 2 2011-07-13 1 3 2021-11-03 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _struct_ref_seq_dif.details Y BNL 1995-12-14 REL REL 1 AS IN X-PLOR PARALLHDG.PRO STRUCTURES WERE CALCULATED USING A SIMULATED ANNEALING PROTOCOL IN X-PLOR. INPUT CONSTRAINTS ARE AS FOLLOWS: 1659 NUCLEAR OVERHAUSER ENHANCEMENT (NOE) (799 INTRA-RESIDUE; 342 SEQUENTIAL (I-J =1); 236 MEDIUM-RANGE INTERRESIDUE (<1 I-J <=5); 282 LONG-RANGE INTERRESIDUE (I-J >5)); 38 PAIRS OF HYDROGEN-BOND RESTRAINTS; 76 PHI TORSION ANGLE RESTRAINTS. PSEUDOATOM POSITIONS WERE USED FOR CONSTRAINTS INVOLVING METHYLENE, AROMATIC, AND METHYL PROTONS. THE COORDINATES DEPOSITED HERE ARE OBTAINED BY AVERAGING 25 CONVERGED STRUCTURES PRIOR TO A RESTRAINED ENERGY MINIMIZATION. A COMPARISON OF THE FAMILY OF THE 25 STRUCTURES WITH THE AVERAGED STRUCTURE GIVES RMSD VALUES OF 0.88 ANGSTROMS FOR ALL (N,CA,C') EXCEPT RESIDUES 28 - 39, AND 0.41 ANGSTROMS FOR (N,CA,C') OF HELICAL REGIONS (RESIDUES 16 - 26, 42 - 49, 54 - 67, 72 - 84, AND 104 - 122). BRUNGER refinement X-PLOR 3.1 ALA 14 n 1 ALA 14 A ASN 15 n 2 ASN 15 A CYS 16 n 3 CYS 16 A SER 17 n 4 SER 17 A ILE 18 n 5 ILE 18 A MET 19 n 6 MET 19 A ILE 20 n 7 ILE 20 A ASP 21 n 8 ASP 21 A GLU 22 n 9 GLU 22 A ILE 23 n 10 ILE 23 A ILE 24 n 11 ILE 24 A HIS 25 n 12 HIS 25 A HIS 26 n 13 HIS 26 A LEU 27 n 14 LEU 27 A LYS 28 n 15 LYS 28 A ARG 29 n 16 ARG 29 A PRO 30 n 17 PRO 30 A PRO 31 n 18 PRO 31 A ASN 32 n 19 ASN 32 A PRO 33 n 20 PRO 33 A LEU 34 n 21 LEU 34 A LEU 35 n 22 LEU 35 A ASP 36 n 23 ASP 36 A PRO 37 n 24 PRO 37 A ASN 38 n 25 ASN 38 A ASN 39 n 26 ASN 39 A LEU 40 n 27 LEU 40 A ASN 41 n 28 ASN 41 A SER 42 n 29 SER 42 A GLU 43 n 30 GLU 43 A ASP 44 n 31 ASP 44 A MET 45 n 32 MET 45 A ASP 46 n 33 ASP 46 A ILE 47 n 34 ILE 47 A LEU 48 n 35 LEU 48 A MET 49 n 36 MET 49 A GLU 50 n 37 GLU 50 A ARG 51 n 38 ARG 51 A ASN 52 n 39 ASN 52 A LEU 53 n 40 LEU 53 A ARG 54 n 41 ARG 54 A THR 55 n 42 THR 55 A PRO 56 n 43 PRO 56 A ASN 57 n 44 ASN 57 A LEU 58 n 45 LEU 58 A LEU 59 n 46 LEU 59 A ALA 60 n 47 ALA 60 A PHE 61 n 48 PHE 61 A VAL 62 n 49 VAL 62 A ARG 63 n 50 ARG 63 A ALA 64 n 51 ALA 64 A VAL 65 n 52 VAL 65 A LYS 66 n 53 LYS 66 A HIS 67 n 54 HIS 67 A LEU 68 n 55 LEU 68 A GLU 69 n 56 GLU 69 A ASN 70 n 57 ASN 70 A ALA 71 n 58 ALA 71 A SER 72 n 59 SER 72 A ALA 73 n 60 ALA 73 A ILE 74 n 61 ILE 74 A GLU 75 n 62 GLU 75 A SER 76 n 63 SER 76 A ILE 77 n 64 ILE 77 A LEU 78 n 65 LEU 78 A LYS 79 n 66 LYS 79 A ASN 80 n 67 ASN 80 A LEU 81 n 68 LEU 81 A LEU 82 n 69 LEU 82 A PRO 83 n 70 PRO 83 A CYS 84 n 71 CYS 84 A LEU 85 n 72 LEU 85 A PRO 86 n 73 PRO 86 A LEU 87 n 74 LEU 87 A ALA 88 n 75 ALA 88 A THR 89 n 76 THR 89 A ALA 90 n 77 ALA 90 A ALA 91 n 78 ALA 91 A PRO 92 n 79 PRO 92 A THR 93 n 80 THR 93 A ARG 94 n 81 ARG 94 A HIS 95 n 82 HIS 95 A PRO 96 n 83 PRO 96 A ILE 97 n 84 ILE 97 A HIS 98 n 85 HIS 98 A ILE 99 n 86 ILE 99 A LYS 100 n 87 LYS 100 A ASP 101 n 88 ASP 101 A GLY 102 n 89 GLY 102 A ASP 103 n 90 ASP 103 A TRP 104 n 91 TRP 104 A ASN 105 n 92 ASN 105 A GLU 106 n 93 GLU 106 A PHE 107 n 94 PHE 107 A ARG 108 n 95 ARG 108 A ARG 109 n 96 ARG 109 A LYS 110 n 97 LYS 110 A LEU 111 n 98 LEU 111 A THR 112 n 99 THR 112 A PHE 113 n 100 PHE 113 A TYR 114 n 101 TYR 114 A LEU 115 n 102 LEU 115 A LYS 116 n 103 LYS 116 A THR 117 n 104 THR 117 A LEU 118 n 105 LEU 118 A GLU 119 n 106 GLU 119 A ASN 120 n 107 ASN 120 A ALA 121 n 108 ALA 121 A GLN 122 n 109 GLN 122 A ALA 123 n 110 ALA 123 A GLN 124 n 111 GLN 124 A GLN 125 n 112 GLN 125 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 1 A ASN 15 -150.16 53.31 1 A LEU 27 -113.24 56.50 1 A LYS 28 -158.44 68.20 1 A PRO 31 -77.64 -73.22 1 A ASN 38 -54.05 88.80 1 A ALA 90 2.77 66.28 1 A ALA 91 -177.16 143.39 1 A THR 93 -150.48 -45.85 1 A PRO 96 -78.18 -164.52 1 A ILE 97 -67.86 -171.86 1 A LYS 100 -119.46 -161.46 1 A TYR 114 -68.06 -84.58 1 A ALA 123 -123.60 -74.56 1 A GLN 124 59.93 94.96 model building X-PLOR 3.1 refinement X-PLOR 3.1 phasing X-PLOR 3.1 HUMAN INTERLEUKIN 3 (IL-3) MUTANT WITH TRUNCATION AT BOTH N-AND C-TERMINI AND 14 RESIDUE CHANGES, NMR, MINIMIZED AVERAGE STRUCTURE 1 Y N A CYS 16 A CYS 3 HELX_P A HIS 26 A HIS 13 1 1 11 A SER 42 A SER 29 HELX_P A MET 49 A MET 36 1 2 8 A ARG 54 A ARG 41 HELX_P A HIS 67 A HIS 54 1 3 14 A SER 72 A SER 59 HELX_P A CYS 84 A CYS 71 1 4 13 A TRP 104 A TRP 91 HELX_P A GLN 122 A GLN 109 1 5 19 disulf 2.021 A CYS 16 A SG CYS 3 1_555 A CYS 84 A SG CYS 71 1_555 CYTOKINE HEMATOPOIETIC GROWTH FACTOR, COLONY-STIMULATING FACTOR, CYTOKINE IL3_HUMAN UNP 1 1 P08700 MSRLPVLLLLQLLVRPGLQAPMTQTTPLKTSWVNCSNMIDEIITHLKQPPLPLLDFNNLNGEDQDILMENNLRRPNLEAF NRAVKSLQNASAIESILKNLLPCLPLATAAPTRHPIHIKDGDWNEFRRKLTFYLKTLENAQAQQTTLSLAIF 34 144 1JLI 15 125 P08700 A 1 2 112 1 ASN engineered mutation ILE 18 1JLI A P08700 UNP 37 5 1 THR engineered mutation HIS 25 1JLI A P08700 UNP 44 12 1 GLN engineered mutation ARG 29 1JLI A P08700 UNP 48 16 1 LEU engineered mutation ASN 32 1JLI A P08700 UNP 51 19 1 PHE engineered mutation PRO 37 1JLI A P08700 UNP 56 24 1 GLY engineered mutation SER 42 1JLI A P08700 UNP 61 29 1 GLN engineered mutation MET 45 1JLI A P08700 UNP 64 32 1 ASN engineered mutation ARG 51 1JLI A P08700 UNP 70 38 1 ARG engineered mutation THR 55 1JLI A P08700 UNP 74 42 1 GLU engineered mutation LEU 59 1JLI A P08700 UNP 78 46 1 ASN engineered mutation VAL 62 1JLI A P08700 UNP 81 49 1 SER engineered mutation HIS 67 1JLI A P08700 UNP 86 54 1 GLN engineered mutation GLU 69 1JLI A P08700 UNP 88 56 1 P 1